The first 3 months on Mounjaro or Wegovy are mostly about stepping up the dose. Both start low and go up in steps of at least 4 weeks, or a month for the Wegovy tablets, to make stomach side effects less likely, so by week 12 nobody can be on the highest dose yet. The main trials reported their average results after 64 to 72 weeks, and for the injections, NICE and the UK prescribing information set the first formal review at 6 months, not 3. Early on, what helps is noticing your appetite, side effects and how meals change.
The first few weeks on a weight-loss injection or tablet can feel like a lot of waiting. You start on a dose lower than the one you'll be on later, you're watching for side effects, and everyone online seems to have a number for what you "should" see by month three.
I want to deal with that number first, because it doesn't exist in the way people think. What the first 3 months are really about is getting used to the medicine, one dose step at a time. So that's what this page covers: why the steps are there, what people commonly notice, what's worth writing down, and when to speak to your GP or prescriber.
Why the first 3 months are mostly dose steps
Both medicines start low and go up slowly, and the prescribing information (the SmPC) says why. Wegovy's says the dose is increased over 16 weeks "to reduce the likelihood of gastrointestinal symptoms". Mounjaro's says nausea, diarrhoea and vomiting happened mainly while the dose was going up, and eased over time.
Diagram, not to scale
At week 12, partway up the ladder
So at week 12, people are partway up the ladder. Here's the fastest each SmPC allows.
| Medicine | Starts at | Then | Highest by week 12 |
|---|---|---|---|
| Mounjaro Weekly KwikPen | 2.5 mg for 4 weeks | Then 5 mg. If needed it can go up 2.5 mg at a time, after at least 4 weeks on each dose | 7.5 mg |
| Wegovy injection Weekly pen | 0.25 mg for 4 weeks | Then 0.5 mg, 1 mg and 1.7 mg, 4 weeks each, and 2.4 mg from week 17 | 1 mg |
| Wegovy tablets Daily tablet | 1.5 mg for a month | Then 4 mg, 9 mg and 25 mg, at least a month on each | 9 mg |
That's the fastest pace, not a plan for you. Your prescriber sets your doses and may keep you on one for longer. The Wegovy SmPC says that with significant stomach symptoms, the prescriber can consider delaying the next step, or going back to the previous dose until things settle. Wegovy's 7.2 mg dose, where it's used, comes after at least 4 weeks on 2.4 mg. Our Mounjaro dose chart has the details for Mounjaro.
What the trials can and can't tell you about month 3
The trials behind these medicines were long. Mounjaro's main weight trial, SURMOUNT-1, ran for 72 weeks. Wegovy's, STEP 1, ran for 68 weeks, and the main trial of the tablets for 64. Everyone in them, on the medicine or on placebo, also had advice on eating and activity.
From the UK SmPCs
How long the main trials ran, beside the first 12 weeks
| Trial | Length in weeks |
|---|---|
| Mounjaro: SURMOUNT-1 | 72 |
| Wegovy injection: STEP 1 | 68 |
| Wegovy tablets: main trial | 64 |
Their main results are averages at the end, after people had spent most of a year or more on their full dose. The weeks before that are shown only as a line on a chart, and neither main trial report gives an average for 3 months. If you see one online, it's someone's reading of that chart, or a figure from a different trial.
So I'm not going to give you a number. Partly because there isn't a published one, and partly because an average hides a huge spread between people. Yours is yours.
One more thing from the research, because it comes up a lot. A later analysis of SURMOUNT-1, paid for by Lilly, looked at the people whose weight had changed least by week 12. Most of them saw it change later in the trial. That isn't a reason to change anything yourself. It's a reason not to read too much into month 3.
The 6-month review
Here's something the UK does that I find quite reassuring. For both injections, NICE's guidance and the SmPCs set the first formal review at 6 months, not 3. That's when you and your prescriber decide together whether to carry on. For Mounjaro, the 6 months count from when you reach the highest dose you can manage, so the review comes later than 6 months from your first dose.
From NICE and the UK SmPCs
When the first review comes, on the injections
Dose steps
Most of the first 3 months, one step at a time.
The first formal review
At 6 months on the Wegovy injection. On Mounjaro, 6 months after you reach the highest dose you can manage.
Decide together
You and your prescriber decide whether to carry on.
NICE's guidance is written for the NHS, where Wegovy is prescribed through a specialist weight management service. Private prescribers may work differently, so it's worth asking at the start how and when yours will review things.
What people commonly notice
Appetite
Most people notice their appetite first. These medicines slow down how quickly your stomach empties, so you may feel full sooner and stay full for longer. Some people find food takes up less of their thinking. Others find the change odd, or a bit unsettling, especially if eating has been complicated for them before. Both are worth writing down.
Side effects
The SmPCs list the stomach and gut ones as the most common: nausea, diarrhoea, vomiting, constipation, tummy pain, indigestion and burping. Tiredness and hair loss are listed too. They tend to show up while the dose is going up, which is exactly why the first 3 months are worth keeping track of. Our side effect timeline shows when they usually peak and settle.
How meals change
Portions often get smaller without you deciding they should. Some meals sit heavily, some foods you used to enjoy don't appeal for a while, and on some days nothing sounds good. None of that needs fixing, but it's useful to notice which meals felt comfortable and which didn't.
Eating and drinking enough
With a smaller appetite, it's easy to go a long time without eating, or to forget to drink. The SmPCs warn that being sick and diarrhoea can lead to dehydration, which can affect your kidneys, so fluids matter most on the days you feel unwell. Eating regularly matters too, even if the meals are small. Our piece on regular eating explains why.
If you take the contraceptive pill
The MHRA says that if you take Mounjaro and the pill, you should add a barrier method, such as condoms, for 4 weeks after starting and for 4 weeks after any dose increase. That covers most of the first 3 months, so it's worth raising with your prescriber at the start.
What's worth writing down
You don't need to write everything down. A few lines a day is plenty, and it gives you something real to take to your next appointment, instead of trying to remember how week 5 went.
- Each dose step: the date and the dose, from your pharmacy label
- Side effects: what it was, when it started compared with your dose, how long it lasted, and anything that helped
- Appetite: when you felt hungry, and when you felt full
- Meals: what you ate, in your own words, and how it sat. No numbers needed
- Drinks, especially on days you feel unwell
- How you're feeling about it all, good days and bad
- Questions for your prescriber, as they come up
Weighing yourself is optional. You don't need to step on the scales to keep a record that's useful to you and your prescriber.
How a food journal helps
Why bother writing it down? Mostly because memory isn't reliable, especially across weeks of small changes. A written record lets you spot patterns, like nausea that turns up the day after a dose step, or a meal that never sits well. It also lets your prescriber see what actually happened rather than what you remember, which matters all the more with a review at 6 months. There's a fair amount of research on food diaries, and our piece on why writing it down works goes through it.
If you want somewhere to keep it, Healthcount is a free food journal. You write meals in your own words, add your doses and how you feel, and the numbers are optional. A notebook works too. The point is the record, not the app.
When to speak to your GP or prescriber
Your prescriber would rather hear from you early than late. Get in touch:
- if side effects are making it hard to eat or drink, or you're not sure you're ready for the next dose step
- if you've missed a dose and aren't sure what to do. Each medicine has its own rule, and your pharmacist can help too
- before an operation or a procedure with sedation
- if anything else worries you, even if it seems small
Worth knowing from the start
- If you take insulin or a sulphonylurea for diabetes, ask whether those doses need lowering, because low blood sugar is more likely.
- Neither medicine should be used in pregnancy. The SmPCs say to stop Mounjaro at least 1 month, and Wegovy at least 2 months, before a planned pregnancy.
- On Mounjaro, if you take the contraceptive pill, the MHRA advises adding a barrier method such as condoms for 4 weeks after starting and for 4 weeks after each dose increase.
- Gallstones are listed as a side effect in both SmPCs. Ask your pharmacist what to look out for.
From the Mounjaro and Wegovy SmPCs (sections 4.2, 4.4, 4.6 and 4.8) and the MHRA's GLP-1 guidance (updated 5 February 2026).
From the UK SmPCs
Get help straight away
Severe tummy pain that won't go away
Get medical help straight away: call 111, or 999 if it's an emergency. Both SmPCs name persistent, severe abdominal pain as a sign of pancreatitis.
Swelling of your face, lips, tongue or throat
Or trouble breathing or swallowing. Call 999. Both SmPCs list serious allergic reactions.
Being sick or diarrhoea that won't stop
Contact your GP, pharmacist or NHS 111. Losing a lot of fluid can affect your kidneys.
An operation or sedation coming up
Tell the team you take it. The SmPCs warn that stomach contents can be breathed in under general anaesthesia or deep sedation.
You can report a side effect through the MHRA's Yellow Card scheme.
Frequently asked questions
Is there an average weight change for the first 3 months?
Why does the dose go up so slowly?
What dose will I be on after 3 months?
When is the first review on a weight-loss injection?
What's worth writing down in the first weeks?
When should I speak to my GP or prescriber?
General information from the UK prescribing information, NICE and the MHRA, checked 21 October 2026. It isn't medical advice. Your prescriber decides whether a medicine is right for you, which one, and every dose. Prescribing information changes, so check the current leaflet with your pharmacist.
View sources (9)
- Mounjaro KwikPen: summary of product characteristics, Eli Lilly, revised 29 August 2026, EMC
- Wegovy FlexTouch: summary of product characteristics, Novo Nordisk, revised 09/2026, EMC
- Wegovy 7.2 mg: summary of product characteristics, Novo Nordisk, revised 09/2026, EMC
- Wegovy tablets: summary of product characteristics, Novo Nordisk, revised 06/2026, EMC
- Tirzepatide for managing overweight and obesity, NICE technology appraisal TA1026 (updated 1 September 2025)
- Semaglutide for managing overweight and obesity, NICE technology appraisal TA875 (updated 4 September 2023)
- GLP-1 medicines for weight loss and diabetes: what you need to know, MHRA, GOV.UK (updated 5 February 2026)
- Ard J, Lee CJ, Gudzune K, Addison B, et al. Weight reduction over time in tirzepatide-treated participants by early weight loss response: post hoc analysis in SURMOUNT-1. Diabetes, Obesity and Metabolism, 17 July 2025. PMID 40677091
- The Yellow Card scheme, MHRA



